Fenwick represented Proprio, a surgical technology company that develops surgical navigation and imaging platforms, in its $43 million Series B financing. The round was funded by new and existing investors.
Proprio intends to use the funds to fuel commercialization and address the significant demand for their AI-driven surgical navigation platform in the U.S. and overseas. More information can be obtained from the company’s announcement.
The transaction was led by corporate partner Allison Cooper and associates Myles Gutenkunst and law clerk Ty Chung.